Corcept Therapeutics
CORT
#2488
Rank
C$8.27 B
Marketcap
$79.03
Share price
4.69%
Change (1 day)
122.98%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2024 (TTM): C$0.19 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are C$0.62 Billion. In 2023 the company made an earning of C$0.14 Billion a decrease over its 2022 earnings that were of C$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.19 B29.82%
2023 C$0.14 B-4.75%
2022 C$0.15 B-9.51%
2021 C$0.17 B-2.91%
2020 C$0.17 B14.87%
2019 C$0.15 B24.71%
2018 C$0.12 B69.32%
2017 C$73.48 M419.26%
2016 C$14.15 M-395.64%
2015 -C$4.79 Million-87.53%
2014 -C$38.41 Million-33.44%
2013 -C$57.7 Million
2011 -C$44.96 Million17.84%
2010 -C$38.15 Million35.5%
2009 -C$28.16 Million2.84%
2008 -C$27.38 Million60.81%
2007 -C$17.03 Million-52.14%
2006 -C$35.57 Million20.91%
2005 -C$29.42 Million31.87%
2004 -C$22.31 Million60.54%
2003 -C$13.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$25.57 B 12,731.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.57 Billion-4,899.14%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.70 B 8,781.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$14.11 B 6,980.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$1.69 Billion-945.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$22.92 B 11,402.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$56.59 Million-128.39%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.3 M-90.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.54 B 173.06%๐Ÿ‡บ๐Ÿ‡ธ USA